Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Return on Capital Employed: 2024

  • Artiva Biotherapeutics' Return on Capital Employed was N/A to -0.33% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.33%, marking a year-over-year change of. This contributed to the annual value of -0.46% for FY2024, which is N/A change from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Return on Capital Employed of -0.33% as of Q4 2024, which was up 26.14% from -0.44% recorded in Q3 2024.
  • Over the past 5 years, Artiva Biotherapeutics' Return on Capital Employed peaked at -0.33% during Q4 2024, and registered a low of -0.44% during Q3 2024.
  • In the last 1 years, Artiva Biotherapeutics' Return on Capital Employed had a median value of -0.39% in 2024 and averaged -0.39%.